Aequus Pharmaceuticals Inc.
OTC: AQSZF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Douglas Glen Janzen
- Employees
- 12
- Headquarters
- Vancouver, Canada
- IPO year
- 2015
- Market cap
- $145.9K
- Website
- https://www.aequuspharma.ca
Loading AQSZF…
Loading profile data…Frequently asked questions about AQSZF
What does Aequus Pharmaceuticals Inc. (AQSZF) do?
Aequus Pharmaceuticals Inc. is a specialized pharmaceutical firm based in Vancouver, Canada, dedicated to the development and commercialization of medicinal products across the country. The company concentrates its efforts on several key medical disciplines, including neurological conditions, ophthalmology, and transplantation medicine. Its curr...
Where does AQSZF trade?
Aequus Pharmaceuticals Inc. (AQSZF) trades on the Other OTC.
What sector is AQSZF in?
Aequus Pharmaceuticals Inc. (AQSZF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Aequus Pharmaceuticals Inc.?
Douglas Glen Janzen is the chief executive officer of Aequus Pharmaceuticals Inc. (AQSZF).
Where is Aequus Pharmaceuticals Inc. headquartered?
Aequus Pharmaceuticals Inc. is headquartered in Canada.
Does AQSZF pay a dividend?
Aequus Pharmaceuticals Inc. (AQSZF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AQSZF go public?
Aequus Pharmaceuticals Inc. (AQSZF) completed its initial public offering in 2015.